文献速递睡眠呼吸障碍头颈外科

上颌下颌前移术对阻塞性睡眠呼吸暂停伴2类与3类牙颌面畸形患者的疗效比较

Maxillomandibular Advancement Efficacy in Obstructive Sleep Apnea Patients With Class 2 Versus 3 Dentofacial Deformity.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-07-14

回顾性队列研究比较上颌下颌前移术(MMA)对阻塞性睡眠呼吸暂停(OSA)伴2类与3类牙颌面畸形(DFD)患者的疗效,按术前BMI、年龄和性别匹配28例受试者(每组14例)。结果显示两组术后AHI和Epworth嗜睡量表均较术前下降,2类组AHI从43.42降至9.6(p<.001)、3类组从37.17降至11.81(p=.042);氧减饱和度指数在2类组从30.48降至6.88(p=.024)、在3类组从11.43降至5.44(p=.85)。结论认为在年龄、性别和BMI匹配的受试者中,MMA对2类和3类牙颌面畸形组在客观和主观指标上疗效相当;术前2类组OSA病情更重(AHI和ODI更高),3类组OSA患者可能需要额外关注以改善鼻腔功能结局。

要点

  • MMA对2类和3类牙颌面畸形OSA患者在客观和主观指标上疗效相当。
  • 术前2类组AHI和ODI高于3类组,提示病情更重。
  • 3类组OSA患者可能需要额外关注以改善鼻腔功能结局。

核心结论

  • 在年龄、性别和BMI匹配的受试者中,MMA对2类和3类牙颌面畸形组在客观和主观指标上疗效相当。
  • 术前2类牙颌面畸形OSA患者表现为更严重的疾病,AHI和ODI更高。
  • 3类牙颌面畸形OSA患者可能需要额外关注以改善鼻腔功能结局。

研究设计与样本

  • 回顾性病历审查,于斯坦福睡眠外科中心纳入2014年至2021年间接受MMA的OSA伴2类或3类牙颌面畸形患者,按术前BMI、年龄和性别匹配。
  • 共识别并评估28例匹配受试者,每组14例。
  • 2类和3类组平均年龄(标准差)分别为34.29(10.21)岁和33.86(10.23)岁。

主要发现

  • 2类组AHI从43.42(28.30)降至9.6(5.29)(p<.001);3类组从37.17(35.77)降至11.81(15.74)(p=.042)。
  • 2类组ODI从30.48(24.02)降至6.88(3.39)(p=.024);3类组从11.43(11.40)降至5.44(7.96)(p=.85)。
  • 2类组Epworth嗜睡量表从8.93(5.28)降至3.91(2.70)(p=.018);3类组从10.23(4.38)降至4.22(3.07)(p=.006)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the efficacy of maxillomandibular advancement (MMA) for patients with obstructive sleep apnea (OSA) with class 2 versus 3 dentofacial deformities (DFDs). STUDY DESIGN: Retrospective chart review. SETTING: Tertiary sleep surgery center. METHODS: Patients with OSA and DFD class 2 versus 3 undergoing MMA at Stanford Sleep Surgery between 2014 and 2021 were matched by preoperative body mass index (BMI), age, and sex. Postoperative outcome was compared with polysomnography measures and patient-reported outcome measures (PROMs). RESULTS: Twenty-eight matched subjects, 14 in each deformity group were identified and assessed. The mean age (standard deviation) was 34.29 (10.21) and 33.86 (10.23) for classes 2 and 3, respectively. The apnea-hypopnea index (AHI) decreased from 43.42 (28.30) to 9.6 (5.29) (p < .001) and 37.17 (35.77) to 11.81 (15.74) (p = .042) in class 2 and 3 subjects, respectively. The oxygen desaturation index (ODI) changed from 30.48 (24.02) to 6.88 (3.39) (p = .024) and 11.43 (11.40) to 5.44 (7.96) (p = .85) in class 2 and 3 subjects, respectively. The Epworth sleepiness scale changed from 8.93 (5.28) to 3.91 (2.70) (p = .018) and 10.23 (4.38) to 4.22 (3.07) (p = .006) in class 2 and 3 subjects, respectively. CONCLUSION: Among age, sex, and BMI-matched subjects, MMA is equally effective in both dentofacial class 2 and 3 groups, both objectively and subjectively. Preoperatively, dentofacial class 2 patients with OSA presented with the more severe disease with higher AHI and ODI. Dentofacial class 3 patients with OSA may require additional attention to improve nasal function outcomes.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Abdelwahab M, Taheri N, Eltahir L, et al. Maxillomandibular Advancement Efficacy in Obstructive Sleep Apnea Patients With Class 2 Versus 3 Dentofacial Deformity. Otolaryngol Head Neck Surg. 2023. PMID: 37449410. doi:10.1002/ohn.379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。